Does Your Cannabis Business Have Goodwill or Intangible Assets? Impairment Testing May Be Required

Have you or your clients purchased a business that resulted in recording goodwill or other indefinite-lived intangible assets to your balance sheet? Financial reporting guidance requires that goodwill be tested for impairment at least annually unless an exception applies. If you haven’t yet selected a testing date, many companies choose to use a time in the early part of their fiscal fourth quarter so that the analysis can be finalized ahead of the financial audit busy season.

Beyond the annual testing requirement, cannabis businesses that have been negatively impacted by current market conditions like rising interest rates, high inflation, supply chain disruption, staffing shortages, or valuation reductions in the public capital markets may have a triggering event that would require interim impairment testing. Financial reporting guidance requires that goodwill be tested for impairment when a triggering event occurs that indicates the fair value of the entity (or a reporting unit) may be below its carrying amount.

Some examples of triggering events include:

  • Macroeconomic conditions, such as a deterioration in general economic conditions, limitations on accessing capital, fluctuations in foreign exchange rates, or other developments in equity and credit markets.
  • Industry and market considerations, such as a deterioration in the environment in which an entity operates, an increased competitive environment, a decline in market-dependent multiples or metrics (consider in both absolute terms and relative to peers), a change in the market for an entity’s products or services, or a regulatory or political development.
  • Cost factors such as increases in raw materials, labor, or other costs that have a negative effect on earnings and cash flows.
  • Overall financial performance, such as negative or declining cash flows or a decline in actual or planned revenue or earnings compared with actual and projected results of relevant prior periods.
  • Other relevant entity-specific events, such as changes in management, key personnel, or strategy; loss of key customers; contemplation of receivership; or litigation.
  • Events affecting a reporting unit, such as a change in the composition or carrying amount of its net assets, a more-likely-than-not expectation of selling or disposing of all, or a portion, of a reporting unit, the testing for recoverability of a significant asset group within a reporting unit, or recognition of a goodwill impairment loss in the financial statements of a subsidiary that is a component of a reporting unit.
  • If applicable, a sustained decrease in share price (consider in both absolute terms and relative to peers).

For private companies that elected the alternative available to amortize goodwill and bypass the annual testing requirement, testing is still required upon a triggering event, and the hurdle for passing the impairment testing could be relatively higher or lower depending on the recency of the business combination. For transactions close to the measurement date, goodwill would be higher as a result of subsuming certain intangible assets, i.e., customer relationships and non-competition agreements. For transactions further in the rearview, accumulated amortization may outweigh the higher initial balance.

How Centri Can Help Cannabis Companies

Even if you’ve done your own impairment testing in years past, there are benefits to seeking outside assistance to properly analyze the appropriate measurement date and determine the fair value of the reporting unit(s) relative to the carrying amount. At Centri, our valuation and technical accounting professionals can be a great resource to keep you on track with your financial reporting requirements. Contact us to learn how our experts can help you.

Kevin McLaughlin

Partner | Artificial Intelligence & Cannabis Practice Leader | CPA

Kevin is a Partner at Centri Business Consulting, where he leads the firm’s Artificial Intelligence and Cannabis practice groups. Since joining Centri in December 2014, Kevin has specialized in supporting high-growth companies, particularly those in the AI, technology and cannabis industries, through critical stages of their business lifecycle.. View Kevin McLaughlin's Full Bio

Gerald Cullins

Partner | Valuation Practice Leader

Jerry is a Partner at Centri Business Consulting and the leader of the firm’s Valuation Practice. He has more than 20 years of valuation experience and has analyzed and valued companies for numerous purposes, participating in a wide variety of industries, including technology, life sciences, energy, retail, and manufacturing.. View Gerald Cullins's Full Bio

Mike Fazzolari

Director | MBA, FMVA, ABV

Mike is a Director at Centri Business Consulting. He has 15 years of professional experience, including valuation, investment banking, financial analysis, and project management, of which 10 years are related to valuation. View Mike Fazzolari's Full Bio

About Centri Business Consulting, LLC

Centri Business Consulting provides the highest quality advisory consulting services to its clients by being reliable and responsive to their needs. Centri provides companies with the expertise they need to meet their reporting demands. Centri specializes in financial reportinginternal controlstechnical accounting researchvaluationmergers & acquisitions, and tax, CFO and HR advisory services for companies of various sizes and industries. From complex technical accounting transactions to monthly financial reporting, our professionals can offer any organization the specialized expertise and multilayered skillsets to ensure the project is completed timely and accurately.

Centri’s Capital Conference

The Centri Capital Conference is a one-day event held at Nasdaq on April 22, 2025. This platform will connect investors with executives from presenting companies in various emerging and rapid-growth sectors, including disruptive technologylife scienceshealthcare, and more. The conference will feature industry panels, dynamic speakers, and networking opportunities and will give growth-oriented private and public companies a place to showcase their innovations.

For more details, contact us at capitalconference@centriconsulting.com.

Philadelphia
Eight Penn Center
1628 John F Kennedy Boulevard
Suite 500
Philadelphia, PA 19103
New York City
530 Seventh Avenue
Suite 2201
New York, NY 10018
Raleigh
4509 Creedmoor Rd
Suite 206
Raleigh, NC 27612
Tampa
615 Channelside Drive
Suite 207
Tampa, FL 33602
Atlanta
1175 Peachtree St. NE
Suite 1000
Atlanta, GA 30361
Boston
50 Milk St.
18th Floor
Boston, MA 02109
Tysons Corner
1775 Tysons Blvd
Suite 4131
McLean, VA 22102
Denver
One Tabor Center
1200 17th St.
Floor 26
Denver, CO 80202
Centri Everywhere
1-855-CENTRI1
virtual@CentriConsulting.com

08/23/2023

Centri’s Cultivating Business: Cannabis Industry Real Estate Challenges, featuring Christopher Reece

Join Centri's Cannabis Practice Leader, Kevin McLaughlin, for the latest edition of...

Read More

07/28/2023

Centri’s Cultivating Business: The Importance of Restructuring, featuring Hershel Gerson

Join Centri's Cannabis Practice Leader, Kevin McLaughlin, for the latest edition of...

Read More

04/26/2023

Centri Cannabis’s Cultivating Business featuring Arun Kurichety & Michael Mitgang

Join Centri's Kevin McLaughlin, Leader of Centri's Cannabis Practice, for the latest...

Read More

Related Services